faculty photo

Dina Jacobs, M.D.

Associate Professor of Neurology at the Hospital of the University of Pennsylvania
Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Medical monitor , Penn Medicine Community Vaccine Clinics
Neurology Department Outpatient Clinical Director , Penn Medicine
Department: Neurology

Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Office: (215) 662-3647
Fax: (215) 349-5579
Education:
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.
Post-Graduate Training
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
Certifications
American Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Leah Zuroff 1, Ayman Rezk 1, Koji Shinoda 1, Diego A Espinoza 1, Yehezqel Elyahu 2, Bo Zhang 3, Andrew A Chen 4, Russell T Shinohara 5, Dina Jacobs 1, Roy N Alcalay 6, Thomas F Tropea 7, Alice Chen-Plotkin 7, Alon Monsonego 2, Rui Li 8, Amit Bar-Or: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine 2022.

Ostrem B, Anderson A, Conway S, Healy B, Oh J, Jacobs D, Dobson R, Graham E, Sadovnick D, Zimmerman V, Liu Y, Bove R, Houtchens M.: The effects of pregnancy on MS inflammatory activity are not well described in women with moderate to severe disability. Multiple Sclerosis Journal – Experimental, Translational, Clinical 2022.

Do D, Jacobs D, Wilson J, Wilson E, Virupakshaiah A, and Berger J. : The Effect of Ocrelizumab on JC Virus Antibody Index. CMSC 2022.

Weinstein S, Garland N, Zimmerman V, Reilly E, and Jacobs D.: Impact of a Virtual Wellness Program on Quality-of-Life Measures for Patients Living with MS During the COVID-19 Pandemic International Journal of MS Care 2022.

Mattay R, Davtyan K, Rudie J, Govind M, Jacobs D, Schindler M, Loevner L, Schnall M, Bilello M, Mamourian A, and Cook T.: Economic impact of selective use of contrast for routine follow up MRI of patients with multiple sclerosis. Journal of Neuroimaging 2022.

Anderson A, Jacobs D, Ciplea A, Brandtadter R, Fabian M, Kakara M, Krysko KM, Longbrake E, Reopvic P, Romeo A, West T, Hellwig K, and Bove R. : Ocrelizumab in postpartum women with multiple sclerosis: low transfer into breast milk and reassuring infant development in a multicenter cohort. ACTRIMS 2022, West Palm Beach, FL. 2022.

Graham E, Bakkensen J, Anderson A, Davidson A, Jungheim E, Ostrem B, Bevan C, Balabanov R, Grebenciucova E, Cohen B, Jacobs D, Houtchens M, Kaplan TB, and Bove R.: Impact of continuing disease modifying therapy during assisted reproductive technologies in women with MS: A multicenter analysis of inflammatory activity. ACTRIMS 2022, West Palm Beach, FL. 2022.

Nora Garland, MSW, LSW, Hannah Gilmore, BA, Dina Jacobs, MD, Sona Narula, MD & V. Zimmerman, MSN, MSCN : Exploring Benefits, to Both Patients and Healthcare Providers, of a Dedicated Support Group for Young Adult Patients with Multiple Sclerosis CMSC 2022, National Harbor, Washington, DC 2022.

Anderson A, Poole S, Rowles W, Jacobs D, Bevan C, Brandstadter R, Ciplea AI, Cooper J, Fabian M, Kakara M, Krysko KM,1, Longbrake EE, Marcus J, Repovic P, Riley C, Romeo A, Rutatangwa A, West T, Hale TW, Hellwig K, LaHue SC, Bove R.: Anti-CD20 monoclonal antibody therapy after 59 pregnancies in women with neurological conditions: low breastmilk transfer and normal infant development in a multicenter cohort. ECTRIMS 2022, Amsterdam, NL 2022.

E. Graham, J. Bakkensen, A. Anderson, N. Lancki, A. Davidson, G. Perez-Giraldo, C. Bevan, E. Jungheim, A. Vanderhoff, B. Ostrem, D. Huang, E. Mok-Lin, D. Jacobs, T. Bockow Kaplan, M. Houtchens, R. Bove: Relapse Risk after Fertility Treatments in Women with MS: A Multicenter Analysis of Inflammatory Activity. ECTRIMS 2022, Amsterdan, NL 2022.

back to top
Last updated: 10/04/2022
The Trustees of the University of Pennsylvania